Federated Hermes
KRON

Federated Hermes’s Kronos Bio KRON Stock Holding History

Federated Hermes’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,056
Closed -$2.67K – 2120
2023
Q3 		$2.67K Sell
2,056
-337
-14% -$544 ﹤0.01% 1942
2023
Q2 		$4.12K Sell
2,393
-166,134
-99% -$264K ﹤0.01% 1920
2023
Q1 		$246K Sell
168,527
-2,145
-1% -$4.11K ﹤0.01% 1559
2022
Q4 		$276K Buy
170,672
+3,764
+2% +$8.66K ﹤0.01% 1505
2022
Q3 		$559K Sell
166,908
-118,557
-42% -$535K ﹤0.01% 1307
2022
Q2 		$1.04M Buy
+285,465
New +$1.29M ﹤0.01% 1132

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.83B AUM 20.31% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Federated Hermes's KRON Position: Q4 2023 in Review

Federated Hermes sold out of Kronos Bio (KRON) in Q4 2023, closing a stake of 2,056 shares — an estimated $2.67K sold.

Federated Hermes first reported a position in KRON in Q2 2022 and held it in 6 quarters. The position peaked at $1.04M in Q2 2022. 60 funds tracked by Wall St. Rank hold KRON as of Q4 2023.

  • Federated Hermes reported no remaining Kronos Bio position as of Q4 2023 after selling out during the quarter.
  • Federated Hermes sold 2,056 Kronos Bio shares in Q4 2023, an estimated $2.67K.
  • Federated Hermes first reported a position in Kronos Bio in Q2 2022 and held it in 6 quarters.
  • Federated Hermes's Kronos Bio position peaked at $1.04M in Q2 2022.
  • 60 funds tracked by Wall St. Rank held Kronos Bio as of Q4 2023.

Based on Federated Hermes's 13F filing for Q4 2023, filed 31 Jan 2024.